Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 3 April 1987:
Vol. 236. no. 4797, pp. 81 - 83
DOI: 10.1126/science.3105057

Articles

Science, Vol 236, Issue 4797, 81-83
Copyright © 1987 by American Association for the Advancement of Science


articles

Rheumatoid factor secretion from human Leu-1+ B cells

RR Hardy, K Hayakawa, M Shimizu, K Yamasaki, and T Kishimoto

A human B cell subpopulation identifiable by the expression of the cell surface antigen Leu-1 (CD5) is responsible for most of the immunoglobulin M rheumatoid factor secreted in vitro after the cells are stimulated with Staphylococcus aureus. The ability of B cells bearing the Leu-1 marker (Leu-1+) to secrete rheumatoid factor is present early in development and extends to adulthood, since Leu-1+ B cells from cord blood and from peripheral blood lymphocytes of both normal adults and patients with certain autoimmune conditions secrete rheumatoid factor in comparable amounts. The neonatal enrichment of Leu-1+ B cells, the presence of Leu-1+ B cells in increased frequencies in patients with autoimmune disease, and the involvement of Leu-1+ B cells in autoantibody secretion suggest both developmental and functional homologies between this human B cell subpopulation and the murine Ly-1 B cell subpopulation.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Augmented TLR9-induced Btk activation in PIR-B-deficient B-1 cells provokes excessive autoantibody production and autoimmunity.
T. Kubo, Y. Uchida, Y. Watanabe, M. Abe, A. Nakamura, M. Ono, S. Akira, and T. Takai (2009)
J. Exp. Med. 206, 1971-1982
   Abstract »    Full Text »    PDF »
Identification and Characterization of a Human CD5+ Pre-Naive B Cell Population.
J. Lee, S. Kuchen, R. Fischer, S. Chang, and P. E. Lipsky (2009)
J. Immunol. 182, 4116-4126
   Abstract »    Full Text »    PDF »
Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia.
G. D. Tomaras, N. L. Yates, P. Liu, L. Qin, G. G. Fouda, L. L. Chavez, A. C. Decamp, R. J. Parks, V. C. Ashley, J. T. Lucas, et al. (2008)
J. Virol. 82, 12449-12463
   Abstract »    Full Text »    PDF »
A Subset of Host B Lymphocytes Controls Melanoma Metastasis through a Melanoma Cell Adhesion Molecule/MUC18-Dependent Interaction: Evidence from Mice and Humans.
F. I. Staquicini, A. Tandle, S. K. Libutti, J. Sun, M. Zigler, M. Bar-Eli, F. Aliperti, E. C. Perez, J. E. Gershenwald, M. Mariano, et al. (2008)
Cancer Res. 68, 8419-8428
   Abstract »    Full Text »    PDF »
B-1 B cell development..
R. R. Hardy (2006)
J. Immunol. 177, 2749-2754
   Abstract »    Full Text »    PDF »
Nitric oxide-dependent killing of Cryptococcus neoformans by B-1-derived mononuclear phagocyte.
E. E. B. Ghosn, M. Russo, and S. R. Almeida (2006)
J. Leukoc. Biol. 80, 36-44
   Abstract »    Full Text »    PDF »
Enhanced Apoptosis of Peripheral CD5-Negative B Lymphocytes from Chronically Hepatitis C Virus-Infected Patients: Reversal after Antiviral Treatment.
E. Toubi, A. Kessel, R. Peri, Z. Shmuel, E. Bamberger, E. Sabo, and E. Zuckerman (2004)
J. Virol. 78, 11379-11384
   Abstract »    Full Text »    PDF »
The NOD/SCID chimeric mouse model of human B cell development: studies on the VH4 family immunoglobulin repertoire and implications for SLE.
G R Kolar and J D Capra (2003)
Lupus 12, 158-162
   Abstract »    PDF »
Differentially Regulated Expression and Function of CD22 in Activated B-1 and B-2 Lymphocytes.
F. Lajaunias, L. Nitschke, T. Moll, E. Martinez-Soria, I. Semac, Y. Chicheportiche, R. M. E. Parkhouse, and S. Izui (2002)
J. Immunol. 168, 6078-6083
   Abstract »    Full Text »    PDF »
Mouse B-1 cell-derived mononuclear phagocyte, a novel cellular component of acute non-specific inflammatory exudate.
S. R. Almeida, L. S. Aroeira, E. Frymuller, M. A. A. Dias, C. S. B. Bogsan, J. D. Lopes, and M. Mariano (2001)
Int. Immunol. 13, 1193-1201
   Abstract »    Full Text »    PDF »
High circulating levels of soluble scavenger receptors (sCD5 and sCD6) in patients with primary Sjogren's syndrome.
M. Ramos-Casals, J. Font, M. Garcia-Carrasco, J. Calvo, L. Places, O. Padilla, R. Cervera, M. A. Bowen, F. Lozano, and M. Ingelmo (2001)
Rheumatology 40, 1056-1059
   Abstract »    Full Text »    PDF »
The Identification and Characterization of a Ligand for Bovine CD5.
K. M. Haas and D. M. Estes (2001)
J. Immunol. 166, 3158-3166
   Abstract »    Full Text »    PDF »
Lupus-Specific Antiribonucleoprotein B Cell Tolerance in Nonautoimmune Mice Is Maintained by Differentiation to B-1 and Governed by B Cell Receptor Signaling Thresholds.
Y. Qian, C. Santiago, M. Borrero, T. F. Tedder, and S. H. Clarke (2001)
J. Immunol. 166, 2412-2419
   Abstract »    Full Text »    PDF »
Annexin V Binds to Positively Selected B Cells.
S. R. Dillon, A. Constantinescu, and M. S. Schlissel (2001)
J. Immunol. 166, 58-71
   Abstract »    Full Text »    PDF »
Migration and Differentiation of Autoreactive B-1 Cells Induced by Activated {gamma}/{delta} T Cells in Antierythrocyte Immunoglobulin Transgenic Mice.
N. Watanabe, K. Ikuta, S. Fagarasan, S. Yazumi, T. Chiba, and T. Honjo (2000)
J. Exp. Med. 192, 1577-1586
   Abstract »    Full Text »    PDF »
Chronic lymphocytic leukemia B cells inhibit spontaneous Ig production by autologous bone marrow cells: role of CD95-CD95L interaction.
A. Sampalo, G. Navas, F. Medina, C. Segundo, C. Camara, and J. A. Brieva (2000)
Blood 96, 3168-3174
   Abstract »    Full Text »    PDF »
A VH11V{kappa}9 B Cell Antigen Receptor Drives Generation of CD5+ B Cells Both In Vivo and In Vitro.
M. J. Chumley, J. M. Dal Porto, S. Kawaguchi, J. C. Cambier, D. Nemazee, and R. R. Hardy2 (2000)
J. Immunol. 164, 4586-4593
   Abstract »    Full Text »    PDF »
Identification of a Precursor to Phosphatidyl Choline-Specific B-1 Cells Suggesting That B-1 Cells Differentiate from Splenic Conventional B Cells In Vivo: Cyclosporin A Blocks Differentiation to B-1.
L. W. Arnold, S. K. McCray, C. Tatu, and S. H. Clarke (2000)
J. Immunol. 164, 2924-2930
   Abstract »    Full Text »    PDF »
Annexin V Binds to Viable B Cells and Colocalizes with a Marker of Lipid Rafts upon B Cell Receptor Activation.
S. R. Dillon, M. Mancini, A. Rosen, and M. S. Schlissel (2000)
J. Immunol. 164, 1322-1332
   Abstract »    Full Text »    PDF »
Selection at Multiple Checkpoints Focuses VH12 B Cell Differentiation toward a Single B-1 Cell Specificity.
C. Tatu, J. Ye, L. W. Arnold, and S. H. Clarke (1999)
J. Exp. Med. 190, 903-914
   Abstract »    Full Text »    PDF »
Susceptibility Alleles for Aberrant B-1 Cell Proliferation Involved in Spontaneously Occurring B-Cell Chronic Lymphocytic Leukemia in a Model of New Zealand White Mice.
Y. Hamano, S. Hirose, A. Ida, M. Abe, D. Zhang, S. Kodera, Y. Jiang, J. Shirai, Y. Miura, H. Nishimura, et al. (1998)
Blood 92, 3772-3779
   Abstract »    Full Text »    PDF »
B-1 Cell Development: Evidence for an Uncommitted Immunoglobulin (Ig)M+ B Cell Precursor in B-1 Cell Differentiation.
S. H. Clarke and L. W. Arnold (1998)
J. Exp. Med. 187, 1325-1334
   Abstract »    Full Text »    PDF »
Lack of Intraclonal Diversification in Ig Heavy and Light Chain V Region Genes Expressed by CD5+IgM+ Chronic Lymphocytic Leukemia B Cells: A Multiple Time Point Analysis.
E. W. Schettino, A. Cerutti, N. Chiorazzi, and P. Casali (1998)
J. Immunol. 160, 820-830
   Abstract »    Full Text »    PDF »
Chronic Lymphocytic Leukemia: New Insights into Biology and Therapy.
K. A. Foon, K. R. Rai, and R. P. Gale (1990)
Ann Intern Med 113, 525-539
   Abstract »    PDF »
Increased Numbers of CD5 B Lymphocytes in Schizophrenic Patients.
C. G. McAllister, M. H. Rapaport, D. Pickar, T. A. Podruchny, G. Christison, L. D. Alphs, and S. M. Paul (1989)
Arch Gen Psychiatry 46, 890-894
   Abstract »    PDF »
Effects of Short-term Administration of Antipsychotic Drugs on Lymphocyte Subsets in Schizophrenic Patients.
C. G. McAllister, M. H. Rapaport, D. Pickar, and S. M. Paul (1989)
Arch Gen Psychiatry 46, 956-957
   Abstract »    PDF »
The Biology of the Immune Response.
H. N. Claman (1987)
JAMA 258, 2834-2840
   Abstract »    PDF »
CD5 expression by B lymphocytes and its regulation upon Epstein-Barr virus transformation.
D. Kaplan, D. Smith, H. Meyerson, N. Pecora, and K. Lewandowska (2001)
PNAS 98, 13850-13853
   Abstract »    Full Text »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)